683 Capital Management »

Anterix Inc. Atex shares owned by 683 Capital Management

Quarter-by-quarter ownership of Anterix Inc. Atex (ATEX) shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in Anterix Inc. Atex

Tip: Access up to 7 years of quarterly data

All positions including Anterix Inc. Atex held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Anterix Inc. Atex by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.8M 46k 38.19

More positions owned by 683 Capital Management

Palantir Technologies Cl A Put Option (PLTR)
Eli Lilly & Co. (LLY)
NVIDIA Corporation Put Option (NVDA)
Capital One Financial (COF)
Alnylam Pharmaceuticals (ALNY)
Carvana Cl A (CVNA)
Madrigal Pharmaceuticals Put Option (MDGL)
Tesla Motors Put Option (TSLA)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Protagonist Therapeutics (PTGX)
Praxis Precision Medicines I Com New Put Option (PRAX)
Wave Life Sciences SHS (WVE)
Becton, Dickinson and (BDX)
Kaspi Kz Jsc Sponsored Ads (KSPI)
Anaptysbio Inc Common (ANAB)

View all positions for 683 Capital Management

Top funds holding Anterix Inc. Atex

Owl Creek Asset Management
Heard Capital
BlackRock
Vanguard Group
Vanguard Capital Management
QVT Financial
Jane Street
Dimensional Fund Advisors
GAMCO Asset Management
Garnet Equity Capital Holdings
Geode Capital Management
State Street Corporation
Millennium Management
Gabelli Funds
Marshall Wace

View all funds holding Anterix Inc. Atex